ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Boston, MA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Breast Cancer
Ovarian Cancer
Endometrial Cancer
Neoplasm Metastasis
Non-Small-Cell Lung Carcinoma

Prostate Cancer trials near Boston, MA, USA:

Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

(ADT) in the treatment of metastatic, non-metastatic, and advanced prostate cancers. The first phase of the study is to establish a...

Active, not recruiting
Metastatic Prostate Cancer
Non-metastatic Prostate Cancer
Drug: GNRH-A Goserelin
Drug: Abemaciclib

Phase 1, Phase 2

Praful Ravi, MB BCHir, MRCP

Boston, Massachusetts, United States

of this study is to evaluate the safety, tolerability, and antitumour activity of AZD0754 CAR T-cell therapy in participants with metastatic prostate...

Enrolling
Metastatic Prostate Cancer
Biological: AZD2287
Biological: AZD0754

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Boston, Massachusetts, United States and 14 other locations

This research study is studying an immune-based cancer drug as a possible treatment for prostate cancer.The drug involved ...

Active, not recruiting
Prostate Cancer
Drug: Nivolumab

Phase 2

Beth Israel Lahey Health
Beth Israel Lahey Health

Boston, Massachusetts, United States and 4 other locations

with the radioligand treatment, 177Lu-PSMA-617, is safe in treating prostate cancer and whether the combination is effective in shr ...

Enrolling
Metastatic Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Drug: 177Lu-PSMA-617
Drug: Carboplatin

Phase 1

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Boston, Massachusetts, United States and 2 other locations

used to monitor response to therapy in metastatic hormone sensitive prostate cancer and can be potentially used to optimize future ...

Active, not recruiting
Metastatic Prostate Cancer
Hormone Sensitive Prostate Cancer
Device: PET/CT
Drug: 18F-rhPSMA-7.3

Phase 4

Mass General Brigham
Mass General Brigham

Boston, Massachusetts, United States and 1 other location

improves cardiovascular risk factors in Black men diagnosed with prostate cancer and are undergoing androgen deprivation therapy (A...

Enrolling
Prostate Cancer Metastatic
Prostate Cancer
Other: Aerobic and resistance exercise
Other: Usual Care
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Boston, Massachusetts, United States

purpose of this study is to assess the safety, tolerability, and preliminary efficacy of BMS-986460 in men with Metastatic Castration-resistant Prostate...

Active, not recruiting
Metastatic Castration-resistant Prostate Cancer
Drug: BMS-986460

Phase 1

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Boston, Massachusetts, United States and 6 other locations

The main purpose of this study is to assess the safety and tolerability of AZD0516 as monotherapy and/or in combination with other anti-cancer...

Enrolling
Metastatic Prostate Cancer
Drug: AZD9574
Drug: AZD0516

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Boston, Massachusetts, United States and 50 other locations

Assessment of the safety and efficacy of HLD-0915 as monotherapy in patients with metastatic castration resistant prostate cancer (...

Enrolling
Prostate Cancer (Adenocarcinoma)
Prostate Cancer Metastatic Disease
Drug: HLD-0915

Phase 1, Phase 2

Halda Therapeutics OpCo, Inc.

Boston, Massachusetts, United States and 10 other locations

This study is being conducted to learn more about the safety, tolerability, and effectiveness of an experimental treatment for metastatic prostate...

Enrolling
Prostate Cancer
Drug: AZD6621

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Boston, Massachusetts, United States and 12 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems